Ravishankar Jayadevappa of the Perelman School of Medicine led a study that found androgen deprivation therapy (A.D.T), commonly used to treat prostate cancer, may increase a patient’s risk of dementia. However, he said, A.D.T. is still a lifesaving treatment and shouldn’t be avoided.